UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) ~~September~~March 2919, ~~2025~~2026

PRECISION OPTICS CORPORATION, INC.

(Exact name of registrant as specified in its charter)

Massachusetts	001-10647	04-2795294
(State or other jurisdiction	(Commission	(~~I.R.S.~~IRS Employer
of incorporation)	File Number)	Identification No.)

22 East Broadway Gardner, Massachusetts		01440
(Address of principal executive offices)		(Zip Code)

(Registrant’s telephone number, including area code) (978) 630-1800

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol(s)		Name of each exchange on which registered
Common stock, par value $0.01 per share		POCI		The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.0207 ~~Departure~~Submission of ~~Directors~~Matters orto ~~Certain~~a ~~Officers;~~Vote ~~Election~~ of ~~Directors;~~Security ~~Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Holders.

On March 19, 2026, Precision Optics Corporation, Inc. (bthe “Company” or “we”) held our annual meeting of stockholders. Proxies were solicited pursuant to our definitive proxy statement filed on February 3, 2026, with the Securities and Exchange Commission under Section 14(ea) of the Securities Exchange Act of 1934. The number of shares of common stock that voted on matters presented at the annual meeting was 5,950,539, representing approximately 77.07% of the 7,720,229 shares of common stock outstanding as of January 29, 2026, the record date for the annual meeting. At the annual meeting, stockholders considered and voted on the following proposals, each of which is described in more detail in the proxy statement.

OnProposal October 2, 2025, Precision Optics Corporation, Inc’s (“POCI” or the “Company”) and Mr. Mahesh Lawande mutually agreed to terminate his employment with the Company as of October 31, 2025 (the “Termination Date”). Effective October 1~~, 2025,~~ ~~Mr.~~– ~~Lawande~~Election ~~transitioned to the roll~~ of “Advisor to the President” for the period through his Termination Date. On October 2, 2025, the Company and Mr. Lawande’s entered into a Modification Agreement (the “Modification”) to his Employment Agreement dated March 30, 2023 by and between Mr. Lawande and the Company (the “Employment Agreement”), which Modification provides for the roll of “Advisor to the President” during the month of October 2025 and amends his severance period from six months to seven months following his Termination Date and waives any further right to additional notice under his Employment Agreement.Directors

~~The~~Peter ~~foregoing~~H. ~~description of~~Woodward, ~~the~~Andrew ~~Modification~~J. ~~does~~Miclot, ~~not~~Buell ~~purport~~G. Duncan, toJoseph beP. aPellegrino, ~~complete~~Jr., ~~statement of the parties’ rights~~ and ~~obligations~~Joseph ~~and~~N. isForkey ~~qualified~~were ineach ~~its~~duly ~~entirety by~~elected ~~reference~~as toour ~~the~~directors. ~~full~~The ~~text~~results of the ~~Modification,~~elections awere ~~copy of which is filed~~ as ~~Exhibit 10.1 to this Current Report on Form 8-K and incorporated~~ ~~by reference herein.~~follows:

NOMINEE	FOR	WITHHELD	BROKER NON-VOTES
Peter H. Woodward	2,819,370	254,718	2,876,451
Andrew J. Miclot	2,835,006	239,082	2,876,451
Buell G. Duncan	2,836,742	237,346	2,876,451
Joseph P. Pellegrino, Jr.	2,837,092	236,996	2,876,451
Joseph N. Forkey	2,478,442	595,646	2,876,451

AsProposal ~~previously~~2 ~~announced by~~– ~~the~~Advisory ~~Company,~~Vote effective as of October 1, 2025 (the “Start Date”), the Company appointed Mr. Joseph Traut, 54 years old, as the Company’s Chief Operating Officer. Most recently, Mr. Traut was the VP of Operations for T2 Biosystems (2023-2025), VP of Technology Transfer at Lumira Dx (2021-2022) and VP of Manufacturing Solutions at Ximedica (now Veranex; 2017-2021), with additional positions prior to 2017 in manufacturing engineering, management and leadership. He has consulted to the Company since July 2025 on ~~certain operational~~Executive matters. Mr. Traut has a Master of Business Administration, Management of Technology from Bentley College, Waltham, MA and a Bachelor of Science, Mechanical Engineering Technology from Northeastern University, Boston, MA.Compensation

InOur ~~connection~~stockholders ~~with~~voted ~~his appointment~~upon ~~as Chief Operating Officer, Mr. Traut~~ and ~~the Company entered into an Employment Agreement dated September 29~~approved, ~~2025~~on ~~(the “Employment Agreement”) and a Non-Competition Agreement dated September 29, 2025 (the “Non-Competition Agreement”). Pursuant to his Employment Agreement, Mr. Traut will be compensated at~~ an ~~annual base salary of $275,000, will be eligible for an annual bonus~~ upadvisory ~~to 25% of his annual salary for the fiscal year~~basis, ~~and will be entitled to participate in employee benefit plans offered by~~ the ~~Company. In~~compensation ~~connection~~paid ~~with Mr. Traut joining the Company, the Compensation Committee and Board of the Company approved the grant of an inducement stock option~~ to beour ~~granted~~Named onExecutive ~~his~~Officers ~~Start Date, to purchase 60,000 shares of the Company’s common stock~~ (~~the~~as ~~“Option”). The~~that ~~Option~~term ~~was~~is ~~granted~~defined ~~pursuant~~in toour ~~the~~2025 ~~Nasdaq~~Proxy ~~Rule 5635(c~~Statement)~~(4)~~ ~~inducement~~for ~~grant exception as a component of~~ the ~~individual’s employment~~fiscal ~~compensation~~year ~~and~~ended ~~was~~June granted as an inducement material to his acceptance of employment with the Company. Mr. Traut’s Option has an exercise price equal to the closing price of the Company’s common stock as reported by the Nasdaq Capital Market on October 130, 2025. The ~~Options~~votes ~~have~~on athis ~~ten-year~~proposal ~~term~~were ~~and~~as ~~vest in three equal annual installments, subject to Mr. Traut’s continued service with the Company through the applicable vesting dates.~~follows:

The foregoing description of the Employment Agreement and Non-Competition Agreement does not purport to be a complete statement of the parties’ rights and obligations and is qualified in its entirety by reference to the full text of the Employment Agreement and Non-Competition Agreement, a copy of which is filed as Exhibit 10.2 and 10.3 to this Current Report on Form 8-K and incorporated by reference herein.

FOR	AGAINST	ABSTAIN	BROKER NON-VOTES
3,009,650	4,802	59,636	2,876,451

~~Item~~Proposal ~~9.01~~3 ~~Financial~~– ~~Statements~~Ratification ~~and~~of ~~Exhibits.~~the Appointment of Independent Registered Public Accounting Firm

~~(d) Exhibits~~Our stockholders voted upon and approved the ratification of the appointment of Stowe & Degon, LLC to serve as our independent registered public accounting firm for the fiscal year ending June 30, 2026. The votes on this proposal were as follows:

Exhibit No.		Exhibit Description
FOR	AGAINST	ABSTAIN	BROKER NON-VOTES
10.1		Modification Agreement dated October 2, 2025 by and between Precision Optics Corporation, Inc. and Mahesh Lawande.
5,949,026	415	1,098	0
10.2		Employment Agreement dated September 29, 2025 by and between Precision Optics Corporation, Inc. and Joseph W. Traut.
10.3		Non Competition Agreement dated September 29, 2025 by and between Precision Optics Corporation, Inc. and Joseph W. Traut.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	PRECISION OPTICS CORPORATION, INC.
Dated: October 3, 2025	By:	/s/ Joseph N. Forkey
Dated: March 20, 2026	By:	/s/ Joseph N. Forkey
	Name:	Joseph N. Forkey
	Name: Joseph N. Forkey Title: President
	Title:	President

Filing Compare · PRECISION OPTICS CORPORATION, INC.